Usefulness of serogenetic testing in the management of a young patient with Crohn's disease: Commentary

Given the availability of biologic agents and other effective treatments for CD, I think clinicians should begin to be much more proactive in managing CD. With serogenetic testing, we have an opportunity to think more proactively and consider new information when deciding on a course of treatment. As with all our diagnostic tools - endoscopy, CRP measurements, laboratory tests, and stool studies - serogenetic tests need to be interpreted correctly, and the whole puzzle needs to be put together to determine the best course of action.